About Dr. Joshua Ford

Dr. Joshua Ford is a board-certified Ophthalmologist who received advanced fellowship training in Ophthalmic Plastic and Reconstructive Surgery and Orbital Oncology. He was born on a peanut farm in Sylvester, Georgia and was raised by his eldest brother and sister in a single-wide trailer for many of his formative years. He persevered and earned his undergraduate degree in Chemistry from Yale University and his Medical Doctorate from the Geisel School of Medicine at Dartmouth. He then completed his Ophthalmology residency at Tulane University. While there, he found the love of his life in New Orleans and fell in love with the food and culture of Louisiana. He is proud to call New Orleans his home. 

Dr. Ford later did a fellowship in oculoplastic surgery at MD Anderson Cancer Center, with niche training in eyelid and orbital oncology.

Dr. Ford is a member of the American Academy of Ophthalmology and the American Society of Ophthalmic Plastic and Reconstructive Surgeons. In addition to passionately caring for patients, he is dedicated to research, medical education, and community service. He has numerous peer-reviewed publications and has won many awards at domestic and international conferences for his research.

Based on peer recommendations, Dr. Ford was selected as a Top Ophthalmologist by Newsweek Magazine in 2021 and as a Castle Connolly “Rising Star” in 2023 and "Top Doctor" in 2024. He was also featured in the New Orleans Magazine as a Top Doctor in 2023 and 2024.

Dr. Ford is also very proud to serve our nation's Veterans. As the Chief of Ophthalmology at the VA in Alexandria, Louisiana, he directs the medical and surgical education of the Tulane Ophthalmology residents. 

In his free time, Dr. Ford loves college football, hiking, kayaking, traveling internationally, and gorging on local cuisine.

Joshua R. Ford, MD FACS

EDUCATION

• Geisel School of Medicine at Dartmouth, Hanover, NH 
• Yale University, New Haven, CT

POST-GRADUATE EDUCATION AND TRAINING 

• MD Anderson Cancer Center, Houston, TX

             ASOPRS Fellowship 

• Tulane University, New Orleans, LA

             Ophthalmology Residency

CLINICAL APPOINTMENTS 

• Adjunct Assistant Professor of Ophthalmology

             Tulane University

CERTIFICATIONS

• American Society of Ophthalmic Plastic and Reconstructive Surgery
• American Board of Ophthalmology

1. Naugle T, Thompson J, Ford J, Acosta K, Caplan C, Callahan M, Pharo A, Laplant J, Azar S, Fry C. The posterior auricular muscle complex graft as a porous orbital implant wrap: long-term follow-up over a 31-year period. Orbit. 2023 Nov; 27:1-7.
2. Sobel R, Ford J, Dong W, Shriver E, Griepentrog G, Debnam M, Esmaeli B. Frequency and clinical course of residual orbital masses after treatment of orbital rhabdomyosarcoma. Am J Ophthalmol. 2022 Feb; 234:28-36.
3. Olenczak J, Ford J, Mericli A, Adelman D, Chang E, Hanasono M, Esmaeli B, Kapur S. Surgical and ophthalmologic outcomes of reconstruction in patients treated with eye-sparing surgery and radiation therapy for tumors of the lacrimal drainage apparatus. Ann Plast Surg. 2021 Mar;86(3):292-297.
4. Klug T, Shires C, Dryden S, Ford J. Unusual Cause of Acute Sinusitis and Orbital Abscess in COVID-19 Positive Patient. Int J Surg Case Rep. 2021 Feb;79:164-168.
5. El-Hadad C, Rubin M, Nagarajan P, Ford J, Xu S Jr, Ning J, Esmaeli B. Prognostic factors for orbital exenteration, local recurrent, metastasis, and death from disease in conjunctival squamous cell carcinoma. OPRS. 2021 May;37(3):262-268.
6. Ford J, Rubin ML, Frank SJ, Ning J, Debnam JM, Bell D, El-Naggar A, Ferrarotto R, Esmaeli B. Prognostic factors for local recurrent and survival and impact of local treatments on survival in lacrimal gland carcinoma. Br J Ophthalmol. 2021 Jun;105(6):768-774.
7. Tom A, Bell D, Ford J, Debnam J, Guo Y, Frank S, Esmaeli B. Malignant mixed tumor (carcinoma ex-pleomorphic adenoma) of the lacrimal gland. OPRS. 2020 Sep;36(5):497-502.
8. Hong BY, Ford J, Glitza IC, Torres Cabala CA, Tetzlaff M, Prieto VG, Parker R, Daniel C, Esmaeli B. Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma. OPRS. 2020 Jun 17.
9. Wang J, Ford J, Esmaeli B, Langer P, Esmaili N, Griepentrog GJ, Couch SM, Nguyen J, Gold KG, Duerksen K, Burkat CN, Hartstein ME, Gandhi P, Sobel RK, Moon JY, Barmettler A. Inverted Papilloma of the Orbit and Nasolacrimal System. OPRS. 2020 Jun 4.
10. Sagiv O, Thakar SD, Kandl TJ, Ford J et al. Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma. JAMA Ophthalmol. 2018 Nov 1;136(11):1236-1241.
11. Ford J, Gonzalaz-Barlatay J, Valenzuela A. Early orbital infantile hemangioma that emphasizes the importance of glucose-transporter-1 (GLUT-1). Can J Ophthalmol. 2017 (epub ahead of print)
12. Ford J, Puente M, Valenzuela A. BB extraction from the anterior orbit using the two finger special technique. Can J Ophthalmol. 2017 Aug;52(4):e128-e130.
13. Ford J, Thakar S, Thuro B, Esmaeli B. Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual. OPRS. 2017 Sep/Oct;33(5):317-324.
14. Ford J, Thuro B, Thakar S, Wen-Jen Hwu, Esmaeli B. Immune checkpoint inhibitors for treatment of metastatic melanoma of the orbit and ocular adnexa. OPRS. 2016 Sept 21. (epub ahead of print)
15. MacLean KD, Cole SC, Ford J, Owen L, Mamalis N, Patel BC. Thymic Origin Neuroendocrine Carcinoma Metastasizing to the Orbit in an Otherwise Asymptomatic Patient. OPRS. 2016 JanFeb;32(1):e21-3.
16. Farukhi MA, Werner L, Kohl JC, Gardiner GL, Ford J, Cole SC, Vasavada SA, Noristani R, Mamalis N. Evaluation of uveal and capsule biocompatibility of a single-piece hydrophobic acrylic intraocular lens with ultraviolet-ozone treatment on the posterior surface. J Cataract Refract Surg. 2015 May;41(5):1081-7.
17. Owen LA, Ford J, Mamalis N, Hoffman R, Mifflin M. Congenital complex corneal choristoma associated with unilateral bony calvarial defects, subcutaneous nodules, and alopecia. J AAPOS. 2015 Apr;19(2):185-8.
18. Kohl JC, Werner L, Ford J, Cole SC, Vasavada SA, Gardiner GL, Noristani R, Mamalis N. Long-term uveal and capsular biocompatibility of a new accommodating intraocular lens. J Cataract Refract Surg. 2014 Dec;40(12):2113-9.
19. Ford J, Werner L, Owen L, Vasavada SA, Crandall A. Spontaneous bilateral anterior partial inthe-bag intraocular lens dislocation following routine annual eye examination. J Cataract Refract Surg. 2014 Sep;40(9):1561-4.
20. Ford J, Werner L, Mamalis N. Adjustable intraocular lens power technology. J Cataract Refract Surg. 2014 Jul;40(7):1205-23.
21. Ford J, Tsui E, Lahey T, Zegans ME. Question: Can you identify this condition? Acute retinal necrosis. Can Fam Physician. 2013 Dec;59(12):1307; 1308-10.

1. Ford J and Esmaeli B. Eyelid Tumors. (Ed Bozena Romanowska-Dixon). Onkologia Okulistyczna. 2020.
2. Ford J and Werner L. The Advent of the Femtosecond Laser in Medicine and in Ophthalmology. In “Femtosecond Laser Surgery in Ophthalmology” (Eds. Burkhard Dick, Ronald Gerste, and Tim Shultz). Thiemes. 2018.
3. Ford J. Congenital Glaucoma. In Stagg B and Ambati B - Diagnostic Ophthalmology. Amirsys Publishing, Salt Lake City, UT. 2014.
4. Ford J. Floppy Eyelid Syndrome. In Stagg B and Ambati B - Diagnostic Ophthalmology. Amirsys Publishing, Salt Lake City, UT. 2014.
5. Ford J. Interstitial Keratitis. In Stagg B and Ambati B - Diagnostic Ophthalmology. Amirsys Publishing, Salt Lake City, UT. 2014.
6. Ford J. Recurrent Corneal Erosions. In Stagg B and Ambati B - Diagnostic Ophthalmology. Amirsys Publishing, Salt Lake City, UT. 2014.
7. Ford J. Retinopathy of Prematurity. In Stagg B and Ambati B - Diagnostic Ophthalmology. Amirsys Publishing, Salt Lake City, UT. 2014.